SBIR/STTR Research Award

A Multivalent Lyme Disease Vaccine Targeting Tick-Host-Pathogen Interactions

Award identifier c5f5bd4b8a103368717020edfa94132a0b8a77bcd3a24d8aeca3463df9c3a849Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$599,996

Program and phase

STTR · Phase I

Award year

2014

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
L2 DIAGNOSTICS LLC
Proposal award date
2014-07-01
Contract end date
2016-06-30
UEI
GKA7VH5LFR25
Solicitation number
PA10-124
Topic code
NIAID

Research abstract

DESCRIPTION provided by applicant This proposal seeks to develop a novel vaccine against Lyme disease by targeting Ixodes scapularis proteins critical for Borrelia burgdorferi transmission from the tick to mammalian host Earlier work has identified four tick proteins Salp TRE tHRF and TSLPI that facilitate different steps of spirochete transmission and immunity against these proteins individually provided partial impairment of spirochete transmission to the murine host Simultaneously targeting these proteins might compromise multiple steps of transmission and effectively thwart transmission Towards this new strategy to prevent Lyme disease we will assess the efficacy of vaccine targeting A A combination of Borrelia interacting tick proteins TRE and Salp to impair interactions that facilitate spirochete egress from the gut and interactions that ensure spirochete survival in the host respectively B A combination of Borrelia assisting salivary proteins Tick Salivary Lectin Pathway Inhibitor TSLPI and tick histamine release factor tHRF that do not physically associate with the spirochete but play a significant role in enhancing spirochete survival in the host during transmission and in tick engorgement respectively and C A combination of Borrelia interacting Salp and TRE and Borrelia assisting TSLPI and tHRF tick proteins to effectively thwart spirochete arrival and survival at the tick bite site Such a systematic approach has hitherto not been explored and could in principle also be applicable to thwart other arthropod borne pathogens The success of this multipronged derailment approach will provide the basis for the formulation of a multivalent tick antigenic peptide based vaccine against Lyme disease in Phase II efforts PUBLIC HEALTH RELEVANCE This proposal seeks to develop a safe and effective vaccine against Lyme disease by targeting tick salivary and gut proteins critical for the transmission o the Lyme disease agent from the tick to mammalian host

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

84 SBIR/STTR records share this UEI (1999–2025). Reported award amounts total $45,551,124. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.